Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.8/5
Shenzhen Expressway Co H (548 HK)
Watchlist
87
Analysis
Industrials
•
China
Shenzhen Expressway Company Limited constructs, manages and operates toll highways and expressways in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Jiangsu Expressway (H)
•
10 Oct 2022 00:28
Jiangsu Expressway (177 HK): A Simple yet Attractive Yield Play
Jiangsu Expressway has very secured dividend yield of 8.6% for the next two years. In the meantime, upside may come from sequential earnings...
Osbert Tang, CFA
Follow
290 Views
Share
bullish
•
Shenzhen International
•
31 Aug 2022 00:28
Shenzhen Intl (152 HK): The Toughest Time Should Be over Now
1H22 is bad but behind us now. We anticipate sequential earnings improvement in 2H22 as the impact of pandemic fades. SZI will continue to realise...
Osbert Tang, CFA
Follow
335 Views
Share
bullish
•
Thematic (Sector/Industry)
•
06 Aug 2025 23:30
China & HK Strategy: 1H25 Preview - Where Are the Upside and Downside Surprises?
The companies under our coverage are expected to report 16.8% earnings growth for 1H25, with 2Q25 accelerating to 30.8%. Top performers include...
Osbert Tang, CFA
Follow
214 Views
Share
bullish
•
Thematic (Sector/Industry)
•
23 Apr 2025 23:30
China & HK Strategy: 1Q25 Preview - The Good, the Bad, and the Ugly
Earnings for the companies under our coverage are expected to grow by 47.3% in 1Q25, with Shanghai Electric Group, Anhui Conch, COSCO Shipping...
Osbert Tang, CFA
Follow
324 Views
Share
bearish
•
Quantitative Analysis
•
20 Apr 2025 02:10
A-H Premium Weekly (Apr 18th): Remegen, Shandong Gold Mining, Innocare Pharma
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Remegen, Shandong Gold Mining, Innocare Pharma, China...
Ke Yan, CFA, FRM
Follow
368 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.1
x